WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of FLIR Systems, Inc. (NASDAQ:FLIR) in connection with the proposed acquisition of the company by Teledyne Technologies Incorporated ("Teledyne").  Under the terms of the merger agreement, FLIR shareholders will receive $28.00 in cash and 0.0718 shares of Teledyne common stock for each FLIR share that they own, representing implied per-share merger consideration of $55.47 based upon Teledyne's January 15, 2021 closing price of $382.59.  If you own FLIR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/flir/

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pluralsight, Inc. (NASDAQ:PS) in connection with the proposed acquisition of the company by Vista Equity Partners.  Under the terms of the acquisition agreement, PS shareholders will receive $20.26 per share in cash for each share of PS common stock that they hold.  If you own PS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/news/ps/

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TCF Financial Corporation (NASDAQ:TCF) in connection with the proposed stock-for-stock merger of the company with Huntington Bancshares Incorporated ("Huntington").  Under the terms of the merger agreement, TCF shareholders will receive 3.0028 shares of Huntington common stock for each share of TCF that they hold, representing implied per-share merger consideration of $44.32 based upon Huntington's January 15, 2021 closing price of $14.76.  If you own TCF shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/tcf/

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Seneca Biopharma, Inc. (NASDAQ:SNCA) in connection with the company's proposed merger with Leading BioSciences, Inc. ("LBS").  Under the terms of the agreement, LBS shareholders will receive shares of SNCA, resulting in LBS stockholders owning a majority of the combined company, with SNCA shareholders owning just 26.2% of the surviving combined entity.  If you own SNCA shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslawllp.com/snca/